Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 351

1.

Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells.

Michaelis M, Ha TA, Doerr HW, Cinatl J Jr.

Cardiovasc Res. 2008 Feb 1;77(3):544-50. Epub 2007 Nov 12.

PMID:
18006438
2.

Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition.

Michaelis M, Suhan T, Reinisch A, Reisenauer A, Fleckenstein C, Eikel D, Gümbel H, Doerr HW, Nau H, Cinatl J Jr.

Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3451-7.

PMID:
16123451
3.

Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid.

Michaelis M, Köhler N, Reinisch A, Eikel D, Gravemann U, Doerr HW, Nau H, Cinatl J Jr.

Biochem Pharmacol. 2004 Aug 1;68(3):531-8.

PMID:
15242819
4.

In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate.

Cinatl J, Cinatl J, Weber B, Rabenau H, Gümbel HO, Chenot JF, Scholz M, Encke A, Doerr HW.

Antiviral Res. 1995 Aug;27(4):405-18.

PMID:
8540759
5.

Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.

Tenney DJ, Yamanaka G, Voss SM, Cianci CW, Tuomari AV, Sheaffer AK, Alam M, Colonno RJ.

Antimicrob Agents Chemother. 1997 Dec;41(12):2680-5.

6.

PD0084430: a non-nucleoside inhibitor of human cytomegalovirus replication in vitro.

Meyer AL, Bruening EE, Dunkle WE, Booth RJ, Steinbaugh BA, Vara Prasad JV.

Antiviral Res. 2001 Dec;52(3):289-300.

PMID:
11675146
7.

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.

Biron KK, Harvey RJ, Chamberlain SC, Good SS, Smith AA 3rd, Davis MG, Talarico CL, Miller WH, Ferris R, Dornsife RE, Stanat SC, Drach JC, Townsend LB, Koszalka GW.

Antimicrob Agents Chemother. 2002 Aug;46(8):2365-72.

9.

The effect of short-chain fatty acids on the susceptibility of human umbilical vein endothelial cells to human cytomegalovirus infection.

Wu QH, Ascensao J, Almeida G, Forman SJ, Shanley JD.

J Virol Methods. 1994 Apr;47(1-2):37-50.

PMID:
8051232
10.

Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients.

Sarasini A, Baldanti F, Furione M, Percivalle E, Brerra R, Barbi M, Gerna G.

J Med Virol. 1995 Nov;47(3):237-44.

PMID:
8551275
11.

Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events.

Gerna G, Percivalle E, Baldanti F, Sozzani S, Lanzarini P, Genini E, Lilleri D, Revello MG.

J Virol. 2000 Jun;74(12):5629-38.

12.

The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.

Kaptein SJ, Efferth T, Leis M, Rechter S, Auerochs S, Kalmer M, Bruggeman CA, Vink C, Stamminger T, Marschall M.

Antiviral Res. 2006 Feb;69(2):60-9. Epub 2005 Nov 21.

PMID:
16325931
13.

Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus.

Evers DL, Komazin G, Shin D, Hwang DD, Townsend LB, Drach JC.

Antiviral Res. 2002 Oct;56(1):61-72.

PMID:
12323400
14.

Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells.

Cinatl J Jr, Cinatl J, Vogel JU, Kotchetkov R, Driever PH, Kabickova H, Kornhuber B, Schwabe D, Doerr HW.

Cancer Res. 1998 Jan 15;58(2):367-72.

15.

Inhibitory effect of hexamethylene bisacetamide on replication of human cytomegalovirus.

Kitagawa R, Hagihara K, Uhara M, Matsutani K, Kirita A, Tanaka J.

Arch Virol. 2005 Oct;150(10):1977-91. Epub 2005 Jun 15.

PMID:
15959837
16.

Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.

Herget T, Freitag M, Morbitzer M, Kupfer R, Stamminger T, Marschall M.

Antimicrob Agents Chemother. 2004 Nov;48(11):4154-62.

17.

Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action.

Evers DL, Chao CF, Wang X, Zhang Z, Huong SM, Huang ES.

Antiviral Res. 2005 Dec;68(3):124-34. Epub 2005 Sep 15.

PMID:
16188329
18.

Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase.

Zimmermann A, Wilts H, Lenhardt M, Hahn M, Mertens T.

Antiviral Res. 2000 Oct;48(1):49-60.

PMID:
11080540
19.

Cytomegalovirus infection decreases expression of thrombospondin-1 and -2 in cultured human retinal glial cells: effects of antiviral agents.

Cinatl J Jr, Bittoova M, Margraf S, Vogel JU, Cinatl J, Preiser W, Doerr HW.

J Infect Dis. 2000 Sep;182(3):643-51. Epub 2000 Aug 14.

PMID:
10950755
20.

Rapid determination of antiviral drug susceptibility of human cytomegalovirus by real-time PCR.

Schnepf N, Boiteau N, Petit F, Alain S, Sanson-Le Pors MJ, Mazeron MC.

Antiviral Res. 2009 Jan;81(1):64-7. doi: 10.1016/j.antiviral.2008.09.009. Epub 2008 Nov 6.

PMID:
18992772

Supplemental Content

Support Center